Medtronic Sees 2012 EPS of $3.43 to $3.50 Including $0.04 to $0.06 Dilution

Medtronic, Inc. MDT today provided its initial revenue outlook and diluted earnings per share guidance for fiscal year 2012. The company expects revenue growth in the range of 1 to 3 percent on a constant currency basis, which is consistent with current growth in the company's markets. The company expects diluted EPS in the range of $3.43 to $3.50, which includes approximately $0.04 to $0.06 of dilution from the Ardian acquisition. After adjusting for Ardian dilution and 10 cents of one-time tax benefits received in fiscal year 2011, fiscal year 2012 diluted EPS growth is expected to be in the range of 6 percent to 9 percent.